ASSEMBLY BIOSCIENCES, INC.·4

Jun 5, 4:25 PM ET

Bjorkquist Jeanette M 4

Research Summary

AI-generated summary

Updated

Assembly Biosciences (ASMB) PFO Jeanette Bjorkquist Receives Award

What Happened
Jeanette M. Bjorkquist, the company's PFO & PAO (Principal Financial Officer and Principal Accounting Officer), was granted 3,500 restricted stock units (RSUs) on March 29, 2026. The RSUs were reported at $0.00 per share (award), so no cash was exchanged (total reported value $0). The grant represented 35% of her annual equity award approved March 29, 2026 and was contingent on a stockholder-approved amendment to the company’s 2018 Stock Incentive Plan.

Key Details

  • Transaction type/date: Award (code A) granted March 29, 2026; Form 4 filed June 5, 2026.
  • Price: $0.00 per share; 3,500 RSUs granted (total reported value $0).
  • Issuance condition: RSUs became issuable upon stockholder approval of the Plan Amendment on June 4, 2026.
  • Vesting: Four approximately equal installments, assuming continuous service, on March 29 of 2027, 2028, 2029 and 2030.
  • Shares owned after transaction: Not stated in the provided filing excerpt.
  • Filing timeliness: The Form 4 was filed more than two months after the grant date (filed June 5 for a March 29 transaction), indicating a late report under standard Section 16 timing—this delays public visibility of the award.

Context
RSU grants are a form of compensation and do not reflect an open-market purchase or sale. These units become actual shares only if and when they are issued and vest; they generally require continued employment to vest and are not immediately liquid. Because this grant was contingent on a plan amendment and vests over four years, it primarily reflects compensation structure rather than a near-term insider market signal.